News | March 25, 2022
CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma
Recommendation is based on pivotal data from the phase III POLARIX study
Recommendation is based on pivotal data from the phase III POLARIX study
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Subscribe To Our Newsletter & Stay Updated
